WHO issues emergency use listing to Novavax-Serum Institute's COVID-19 vaccine

Middle East
17-12-2021 | 10:51
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
WHO issues emergency use listing to Novavax-Serum Institute's COVID-19 vaccine
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
0min
WHO issues emergency use listing to Novavax-Serum Institute's COVID-19 vaccine
The World Health Organization on Friday issued an emergency use listing to Covovax, Serum Institute of India's version of Novavax Inc's COVID-19 vaccine.
 
The agency said that Novovax's own vaccine is currently under assessment by the European Medicines Agency, and it will complete its own assessment of this vaccine once the EMA has issued its recommendation.
 
 
REUTERS
 

Breaking Headlines

WHO

Emergency

Use

Listing

Novavax-Serum Institute

COVID-19

Vaccine

Cases

India

Variant

Omicron

Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More